ArticleslgStudy

science

Unapproved Drugs Initiative

Unapproved Drugs Initiative is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Unapproved Drugs Initiative rather than just read about it. In short: Unapproved Drugs Initiative is a program by the U.S Food and Drug Administration announced in June 2006 to remove unapproved drugs from the market. As of October 2011 some 14 categories of drugs have been affected.

Key takeaways

  • Unapproved Drugs Initiative belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Unapproved Drugs Initiative to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Unapproved Drugs Initiative from memory before moving on to harder problems.

Reference excerpt

Unapproved Drugs Initiative is a program by the U.S Food and Drug Administration announced in June 2006 to remove unapproved drugs from the market. As of October 2011 some 14 categories of drugs have been affected. It has been controversial due to the resulting increase in some drug prices. In April 2010, in an editorial in the New England Journal of Medicine (NEJM), A.S. Kesselheim and D.H. Solomon said that the rewards of this legislation are not calibrated to the quality or value of the information produced, that there is no evidence of meaningful improvement to public health, that it would be much less expensive for the FDA or National Institutes of Health to pay for trials themselves on widely available drugs such as colchicine, and that the cost burden falls primarily on patients or their insurers. URL Pharma posted a detailed rebuttal of the NEJM editorial.

Drugs affected Colchicine, (pill price rose from $0.09 to $4.85) Ergotamine Albuterol many others

References

Worked examples

Example 1 — a first encounter with Unapproved Drugs Initiative

Start with the simplest possible case. Write down what Unapproved Drugs Initiative claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Unapproved Drugs Initiative before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Unapproved Drugs Initiative ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Unapproved Drugs Initiative

In research
Unapproved Drugs Initiative appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Unapproved Drugs Initiative in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Unapproved Drugs Initiative is common in secondary-school and first-year university syllabi. It links to neighbouring topics Food and Drug Administration, Pharmacology stubs, so understanding it makes those chapters shorter.
In everyday life
Look for Unapproved Drugs Initiative outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Unapproved Drugs Initiative” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Unapproved Drugs Initiative in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Unapproved Drugs Initiative means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Unapproved Drugs Initiative out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Unapproved Drugs Initiative in simple terms?

Unapproved Drugs Initiative is a program by the U.S Food and Drug Administration announced in June 2006 to remove unapproved drugs from the market. As of October 2011 some 14 categories of drugs have been affected.

Why does Unapproved Drugs Initiative matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Unapproved Drugs Initiative?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Unapproved Drugs Initiative.

Tags

  • Food and Drug Administration
  • Pharmacology stubs

Keep exploring